A dedicated platform for the development of innovative treatments for inherited liver diseases in collaboration with CIMA based on AAV-Anc80 from MEE
Targeting life threatening and severely debilitating liver metabolic disorders with high unmet medical need in pediatric and adult patients
Welcome to Vivet Therapeutics
Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases.
Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (FIMA) at the Centro de Investigación Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.